A Calling to Save Lives Through the Marvels of Organ Technology
This Changes Everything.
We’re Not Waiting On Miracles.
We’re Engineering Them.
Together with our clinical partners, we’re working to redefine what’s possible in the field of organ technology. Doing that takes collaboration, knowledge sharing, and mutual support as we grow together with the common goal of saving lives through advances in organ care.
Led by Science. From the Start.
2002
Co-Founder Dr. Peter Friend and colleagues publish the first NMP paper.
2008
OrganOx is spun out independently from University of Oxford.
2013
OrganOx begins product development on metra for liver.
2018
OrganOx metra begins selling into EU and UK transplant centers.
2021
OrganOx metra gains FDA approval for liver transplants in the U.S.
Our Heritage of Academic Rigor
Built on a Foundation of Scientific Research
The academic discipline we bring to our mission dates all the way back to our beginnings in the Innovation Lab at Oxford University. There, our co-founders combined their surgical and engineering expertise to focus on extracorporeal support for patients with liver disease.
Following where the science led, they developed a breakthrough solution:
Machine
Perfusion
The world’s first normothermic machine perfusion (NMP) device for liver transplantation1 was an achievement that changed the course of organ technology.
Future-Focused Leadership
Today, as we continue to push the field of organ technology forward, the work of our founders is driven and amplified by an extraordinary leadership team, bringing together deep expertise in healthcare, engineering, and medical technology.
Meet the Leadership Team
Join the Transformation of Transplantation
Help us shape the future of organ technology, as we envision a world where every organ counts, and new therapies make transplantation the last in a long line of treatment options.
Visit OrganOx Careers
From Our Newsroom
Keep up to date with the latest OrganOx updates and recent news in organ transplantation.
